EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway

Wenyue Hou, Ting Zou, Yichao Yan, Yaolong Zhuang, Shaomei Gao, Huijun Ju, Fei Yao, Qin Yuan, Liang Zhou, Guoqiang Liang, Xiudao Song, Lurong Zhang iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0322056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wenyue Hou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Carcinoma, Hepatocellular, Liver Neoplasms, Neovascularization, Pathologic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Suzhou Gusu Health Talent Research Project, the Medical Science Project of Jiangsu Provincial Health and Wellness Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-O-Methylvisammioside (5OMV), a flavonol compound derived from the traditional Chinese medicine plant Saposhnikovia divaricat , has been shown to inhibit vasospasm induced by High Mobility Group Box 1 (HMGB1) protein. However, its therapeutic potential and molecular mechanisms in HMGB1-induced tumor angiogenesis remain unexplored. Through comprehensive in vitro assays, we demonstrated that 5OMV significantly attenuates HMGB1-induced proliferation, migration, tube formation, and angiogenic activity in human umbilical vein endothelial cells (HUVECs). Parallel in vivo studies using an orthotopic hepatocellular carcinoma model in C57BL/6 mice revealed that 5OMV treatment markedly reduced tumor progression and microvascular density. Mechanistic studies identified that 5OMV downregulates both total and phosphorylated forms of RAGE, MEK, and ERK in HUVECs and tumor tissues. These findings collectively establish that 5OMV exerts anti-tumor effects in hepatocellular carcinoma through targeted modulation of the HMGB1/RAGE/MEK/ERK signaling axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinCarcinoma, HepatocellularLiver NeoplasmsNeovascularization, PathologicMAP Kinase Signaling SystemFlavonoidsHumansAnimalsHuman Umbilical Vein Endothelial CellsMiceReceptor for Advanced Glycation End ProductsCell ProliferationCell MovementMice, Inbred C57BLMaleCell Line, TumorXenograft Model Antitumor AssaysSignal TransductionAngiogenesis

Substanzen

HMGB1 ProteinReceptor for Advanced Glycation End ProductsFlavonoidsHMGB1 protein, human

Autor:innen und Institutionen

  • Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
  • College of Life Sciences, Xuzhou Medical University, Xuzhou, China.
  • Suzhou Academy of Wu Men Chinese Medicine, Suzhou, China.

ORCID-Profile: Lurong Zhang

Förderung

  • National Natural Science Foundation of China
  • the Suzhou Gusu Health Talent Research Project
  • the Medical Science Project of Jiangsu Provincial Health and Wellness Commission
  • the Suzhou Science and Technology Development Program Project
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Hou, W., Zou, T., Yan, Y., Zhuang, Y., Gao, S., Ju, H., Yao, F., Yuan, Q., Zhou, L., Liang, G., Song, X., & Zhang, L. (2025). 5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway. PLOS One. https://doi.org/10.1371/journal.pone.0322056

Vancouver

Hou W, Zou T, Yan Y, Zhuang Y, Gao S, Ju H, et al. 5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway. PLOS One. 2025. doi:10.1371/journal.pone.0322056

BibTeX
@article{Hou2025,
  author = {Hou, Wenyue and Zou, Ting and Yan, Yichao and Zhuang, Yaolong and Gao, Shaomei and Ju, Huijun and Yao, Fei and Yuan, Qin and Zhou, Liang and Liang, Guoqiang and Song, Xiudao and Zhang, Lurong},
  title = {5-O-Methylvisammioside inhibits HMGB1-induced Angiogenesis of hepatocellular carcinoma through RAGE/MEK/ERK signaling pathway},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0322056}
}
Kostenlos starten →